Clinical Trials

FDA Advisers Unanimously Back Moderna’s mRNA Flu Vaccine

Unanimous advisory support advances the shot toward licensure; final FDA action is due by Aug. 5, with CDC coverage unsettled by ACIP’s inability to convene.